荊志成，1971年生，籍貫山東。北京協和醫院心內科主任，北京協和醫學院首批長聘教授；國家自然科學基金委杰青，教育部國家級重大人才項目，科技部國家級重大人才項目入選者；中國農工黨中央委員，中國農工黨北京市委員會副主委，中國農工黨第十六屆中央醫療衛生工作委員會副主任，北京市政協委員，北京市人民政協理論與實踐研究會第五屆理事會成員。被歐洲心臟雜志贊譽為“中國肺血管醫學先鋒”。

主要從事心血管疾病的醫、教、研等工作，特別是針對先天性心臟病、肺栓塞和肺動脈高壓等疑難危重、罕見疾病的臨床、人群、基礎和轉化研究，包括新藥和新醫療器械開發，規范和標準制定，收集保護我國患者遺傳資源，建設全鏈條、全維度生物樣本銀行，國際學術交流，以及中青年人才培養的工作。

爆草黑丝美女|韩国19禁无遮挡啪啪无码网站|91精品国产自产精品男人的天堂|sm鞭打高潮喷水抽搐调教玩弄|果冻在线|日本大尺度吃奶呻吟视频|久久久久黄片|北条麻妃av免费观看|中文字幕一区二区人妻|亚洲最大天堂无码精品区,日韩 欧美 国产精品,国产肉丝袜在线观看,最爽无遮挡行房视频,成人H视频在线观看,糖心vlog冉冉,蜜桃产品一二三产区

1. Zhou YP#, Wei YP#, Yang YJ, Xu XQ, Wu T, Liu C, Mei KY, Peng FH, Wang HP, Sun K, Li JY, Wang HF, Li MT, Wang DL, Miao Q, Jiang X*, Jing ZC*. Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension. J Am Coll Cardiol. 2022 Apr 19;79(15):1477-1488. (IF = 27.203)

2. Jiang X#, Zhou YJ#,Zhou YP#, Peng FH, Wang L, Ma W, Cao YS, Pan X, Zhang GC, Zhang F, Fan FL, Wu BX, Huang W, Yang ZW, Hong C, Li MT, Wang YN, Xu XQ, Wang DL, Zhang SY, Jing ZC*. Clinical features and survival in Taksyasu's arteritis-associated pulmonary hypertension: a nationwide study. Eur Heart J. 2021 Sep 10. (IF = 29.983)

3. Yan Y#, He YY#, Jiang X#, Wang Y, Chen JW, Zhao JH, Ye J, Lian TY, Zhang X, Zhang RJ, Lu D, Guo SS, Xu XQ, Sun K, Li SQ, Zhang LF, Zhang X, Zhang SY, Jing ZC*. DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension. Sci Adv. 2020 Dec 9;6(50). (IF = 14.136)

4. He YY#, Yan Y#, Jiang X, Zhao JH, Wang Z, Wu T, Wang Y, Guo SS, Ye J, Lian TY, Xu XQ, Zhang JL, Sun K, Peng FH, Zhou YP, Mao YM, Zhang X, Chen JW, Zhang SY, Jing ZC*, Spermine promotes pulmonary vascular remodeling and its synthase is a therapeutic target for pulmonary arterial hypertension. Eur Respir J. 2020 Nov 5;56(5):2000522.  doi: 10.1183/13993003.00522-2020. (IF = 16.671)

5. Wang XJ#, Xu XQ#, Sun K#, Liu KQ, Li SQ, Jiang X, Zhao QH, Wang L, Peng FH, Ye J, Wu Y, Jiang R, Zhang J, Huang W, Bei WB, Yan Y, Li JH, Liu QQ, Li S, Wang Y, Zhang SY, Zhang X, Jing ZC*. Association of rare PTGIS variants with susceptibility and pulmonary vascular response in patients with idiopathic pulmonary arterial hypertension. JAMA Cardiol. 2020 Apr 1; 5(6): 677-684. (IF=14.676, R)

6. Wang XJ#, Lian TY#, Jiang X, Liu SF, Li SQ, Jiang R, Wu WH, Ye J, Cheng CY, Du Y, Xu XQ, Wu Y, Peng FH, Sun K, Mao YM, Yu H, Liang C, John YJ, Zhang SY, Zhang X, Jing ZC*. Germline BMP9 mutation causes idiopathic pulmonary arterial hypertension. Eur Respir J. 2019 Mar 14;53(3):1801609. doi: 10.1183/13993003.01609-2018. (IF=12.399, R)

7. Jing ZC#*, Parikh K, Pulido T, Jerjes-Sanchez C, White RJ, Allen R, Torbicki A, Xu KF, Yehle D, Arneson C, Laliberte K, and Rubin LJ. Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized controlled trial. Circulation.2013 Feb 5;127(5):624-633. (IF=14.948, C100, F1000, PIII)

8. Jing ZC#*, Yu ZX, Shen JY, Wu BX, Xu KF, Zhu XY, Pan L, Zhang ZL, Liu XQ, Zhang YS, Jiang X, Galiè Nfor the Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension (EVALUATION) Study. Vadenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study.Am J Respir Crit Care Med. 2011, 183(12):1723-1729. (IF=11.080, R, PIII)

9. Jing ZC#*, Jing X#, Han ZY#, Xu XQ, Wang Y, Wu Y, Lv H, Ma CR, Yang YJ, Pu JL. Iloprost for Pulmonary Vasodilator Testing in Idiopathic Pulmonary Arterial Hypertension. Eur Respir J. 2009 Jun;33:1354-1360. (IF=5.527, R)

10. Jing ZC#, Xu XQ#, Han ZY#, Wu Y, Deng KW, Wang H, Wang ZW, Cheng XS, Xu B, Hu SS,Hui RT, Yang YJ. Registry and survival study of Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest. 2007 Aug;132:373-379. (IF=4.143, C100,F1000)